Stephen Hoge, President at Moderna, Inc. (MRNA), sold 53,336 shares at $51.37 ($2.7M) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($2.7M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |
| MRNA | SELL | 2024-12-04 | $14K | — | Filing → |